ホーム › 非小細胞肺癌 › テキサス › The Woodlands
The Woodlands、TXにおける非小細胞肺癌の臨床試験
The Woodlandsとその周辺地域(約30マイル以内)の拠点で、非小細胞肺癌に関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト(英語)
ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- Houston Methodist The Woodlands Hospital, The Woodlands
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
被験者募集中第1相
- The University of Texas MD Anderson Cancer Center - Conroe, Conroe · 11マイル先
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
被験者募集中第3相
- Texas Oncology - Gulf Coast, The Woodlands
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
被験者募集中第3相
- Texas Oncology - Gulf Coast, The Woodlands
- The University of Texas, MD Anderson Cancer Center - Woodlands, Conroe · 11マイル先
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
被験者募集中第3相
- Texas Oncology - Gulf Coast, The Woodlands
- Kelsey-Seybold Clinic - Springwoods Village Campus, Spring · 7マイル先
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Community Clinical Trials, Spring · 7マイル先
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
被験者募集中第3相
- Renovatio Clinical, The Woodlands
- Woodlands Radiology, The Woodlands
- The University of Texas, MD Anderson Cancer Center - Woodlands, Conroe · 11マイル先
- 他1件
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
被験者募集中第3相
- USO - US Oncology Research Network, The Woodlands
Pan-tumor MRD Study
被験者募集中観察研究
- Community Clinical Trials, Kingwood · 20マイル先
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
被験者募集中第3相
- Research Site, Kingwood · 20マイル先
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
被験者募集中第3相
- Research Site, Kingwood · 20マイル先
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
被験者募集中第2/3相
- USOR - Texas Oncology - The Woodlands, The Woodlands
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
被験者募集中第3相
- Lumi Research, Kingwood · 20マイル先
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第3相
- Renovatio Clinical, The Woodlands
- Community Clinical Trials, Kingwood · 20マイル先
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
被験者募集中第2相
- MD Anderson The Woodlands, Conroe · 11マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
The Woodlandsにおける他の研究
- 肥満症12件の研究
- 過体重10件の研究
- 乳がん10件の研究
- 黄斑変性症9件の研究
- 心血管疾患9件の研究
- 転移性癌9件の研究
- 2型糖尿病7件の研究
- 心不全7件の研究
- 肺がん7件の研究
- 動脈硬化6件の研究
- 地図状萎縮6件の研究
- 前立腺がん6件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。